XANDRA
GARCÍA GONZÁLEZ
Profesora asociada de Ciencias de la Salud
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (27)
2024
-
Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario
International Journal of Molecular Sciences, Vol. 25, Núm. 6
2023
-
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Frontiers in Oncology, Vol. 13
-
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
Journal of Personalized Medicine, Vol. 13, Núm. 3
2022
-
PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort
Biomedicine and Pharmacotherapy, Vol. 146
-
Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy
Clinical Microbiology and Infection, Vol. 28, Núm. 9, pp. 1287.e9-1287.e15
2021
-
Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study
BMC Pulmonary Medicine, Vol. 21, Núm. 1
-
Dpyd exome, mrna expression and uracil levels in early severe toxicity to fluoropyrimidines: An extreme phenotype approach
Journal of Personalized Medicine, Vol. 11, Núm. 8
-
Pharmacogenetics to avoid adverse reactions in cardiology: Ready for implementation?
Journal of Personalized Medicine, Vol. 11, Núm. 11
-
Valganciclovir—Ganciclovir use and systematic therapeutic drug monitoring. An invitation to antiviral stewardship
Antibiotics, Vol. 10, Núm. 1, pp. 1-18
2020
-
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis
Pharmacological Research, Vol. 152
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
-
Improving surgical antibiotic prophylaxis adherence and reducing hospital readmissions: A bundle of interventions including health information technologies
European Journal of Hospital Pharmacy, Vol. 27, Núm. 4, pp. 237-242
-
New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine
Cancer Chemotherapy and Pharmacology, Vol. 86, Núm. 1, pp. 45-54
-
Topical Administration of Amphotericin B as an Effective Adjuvant Treatment for a Deep Fungal Infection of Diabetic Foot Injury
American journal of therapeutics, Vol. 27, Núm. 6, pp. e670-e671
2019
-
Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution
International Journal of Antimicrobial Agents, Vol. 53, Núm. 1, pp. 40-48
-
Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin
Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 3, pp. 694-698
2018
-
Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan
Pharmacological Research, Vol. 136, pp. 133-139
-
Drug cost avoidance resulting from breast cancer clinical trials
European Journal of Clinical Pharmacy, Vol. 20, Núm. 1, pp. 6-10
-
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
Annals of Hematology, Vol. 97, Núm. 11, pp. 2089-2098
-
Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene
Cancer Management and Research, Vol. 10, pp. 4517-4522